**Introduction:** Vascularized composite allografts are potential surgical solutions for patients with traumatic or disfiguring injuries but are highly immunogenic and require elevated levels of immunosuppression. Because of their significant muscle components, VCAs are vulnerable to ischemia reperfusion injury (IRI), an inflammatory process that may predispose to rejection. Reducing IRI may improve graft function and reduce the risk of long term rejection. We have developed a syngeneic rat hind limb transplant model to test approaches for reducing IRI-related inflammation after VCA transplantation.

**Methods:** The right hind limb of the donor is removed, the femoral artery is cannulated and flushed with heparinized lactate ringers, and the limb is wrapped in wet gauze and maintained at room temperature or 4^o^C. After 6 or 24 hours of ischemia, the recipients right hind limb is removed and the donor limb is attached. Skin and muscle were obtained pre-implantation and at post-op day 5 and examined using TUNEL and H&E stains to quantify the extent of injury and inflammation.

**Results:** All animals showed signs of histologic inflammation by post-op day 5. 1 hour post-op histologic samples had minimal inflammatory infiltrates. By 6 hour post-op inflammation was witnessed in and throughout the dermis and endomysial. Apoptosis was seen in all 6 and 24 hour samples.

**Conclusion:** Using a syngeneic model of VCA transplantation with rat hind limbs creates an ideal IRI platform. Further directions include extending this model to galectin-3 knockout rats to determine if inflammatory infiltration occurs at varied rates.
